Koninklijke Philips Electronics N.V.

This report comprises a copy the following press releases entitled:

- - “Philips announces completion of sale of Set-Top Boxes and Connectivity
Solutions businesses to Pace Micro Technology of the UK”, dated April 21, 2008;
- - “Philips plans to participate in TSMC share repurchase program”, dated May 13,
2008;
- - “Philips to acquire Brazilian patient monitoring and critical care company
DixtalBiomédica e Tecnologia”, dated May 13, 2008;
- - “Philips agrees to sell MedQuist stake to CBay Systems”, dated May 22, 2008;
- - “Philips completes cancellation of 36.6 million shares”, dated June 3, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Koninklijke Philips Electronics N.V.

Date: June 5, 2008	By:	/s/ E.P. Coutinho
	Name:	E.P. Coutinho
	Title:	General Secretary

EXHIBIT INDEX

Exhibit No.		Description

99.1		Press release
99.2		Press release
99.3		Press release
99.4		Press release
99.5		Press release

EX-99.1 2 exhibit1.htm EX-99.1 Exhibit EX-99.1

Philips announces completion of sale of Set-Top Boxes and Connectivity Solutions businesses to Pace Micro Technology of the UK

Monday, April 21, 2008

Amsterdam, The Netherlands – Royal Philips Electronics (AEX: PHI, NYSE: PHG) today announced it has completed the sale of its Set-Top Boxes (STB) and Connectivity Solutions (CS) businesses, which were part of its Home Networks business unit within its Consumer Lifestyle sector, to U.K.-based technology provider Pace Micro Technology (FTSE: PIC).
Philips received 64.5 million Pace shares, representing a 21.6% shareholding, with an approximate current market value of EUR 75 million. In addition, Philips will receive a total cash payment of EUR 5 million in the coming three years. The transaction will result in a gain of approximately EUR 55 million to be booked in the results of Philips’ Consumer Lifestyle sector in the second quarter of 2008.
Generating revenues of EUR 416 million in 2007, the STB and CS businesses together employ approximately 320 people, predominantly in France, who will transfer to Pace as part of the transaction. The transaction combines the strengths of two leading players in the industry, creating one of the largest set-top-box players in the world at a time when the shift from analog to digital TV is rapidly increasing.

For further information, please contact:
Jayson Otke
Philips Corporate Communications
Tel: +31 20 5977215
Email: jayson.otke@philips.com

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions through the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide. With sales of EUR 27 billion in 2007, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions for personal wellbeing. News from Philips is located at www.philips.com/newscenter.

About Pace Micro Technology
Pace Micro Technology plc (pic.l) is a leading technology developer for the global payTV industry. Pace’s main focus is on creating intelligent and innovative products and services that benefit our customers and fuel the development of digital TV. Over the last 25 years, Pace has developed one of the world’s most experienced specialist engineering teams and is now the partner of choice for leading payTV operators across the globe. Pace’s international headquarters are in Saltaire, West Yorkshire, UK, with further offices in the USA, France, India and Hong Kong. For more information on Pace, please visit www.pacemicro.com.

Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements in this announcement are based upon information known to Philips on the date of this announcement. Philips undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise

Philips plans to participate in TSMC share repurchase program

Tuesday, May 13, 2008

Amsterdam, The Netherlands – Royal Philips Electronics (NYSE:PHG, AEX:PHI) today announced that, market conditions permitting, it plans to sell common shares in Taiwan Semiconductor Manufacturing Company Ltd. (TAIEX: 2330, NYSE: TSM) in a share repurchase program as announced by TSMC.

This TSMC share repurchase program is part of the fourth step in the multi-phased plan to facilitate an orderly exit by Philips from its shareholding in TSMC as announced by Philips and TSMC on March 9, 2007. This plan aims to reduce Philips’ holding in TSMC to zero before the end of 2010. Today, TSMC has announced it plans to execute this share buyback program via open market transactions on the Taiwan Stock Exchange for up to USD 1 billion worth of shares. Philips plans to participate in additional share repurchase programs in the next years as part of its effort to further build down its holding in TSMC.

Currently, Philips holds approximately 1.3 billion TSMC shares representing approximately 5% of TSMC’s issued shares. This total stake is worth approximately USD 2.8 billion at current market prices of TSMC shares.

For more information, please contact:
Arent Jan Hesselink
Philips Corporate Communications
Tel: +31 20 59 77415
Email: arentjan.hesselink@philips.com

Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. In particular, the offer and sale by Philips of TSMC shares, and the proceeds of any such sales, will depend on equity capital market conditions, particularly those affecting the semiconductor industry.

This release does not constitute an offer of any securities for sale. Any offer or sale of securities shall be made by means of a registration statement filed with the U.S. Securities and Exchange Commission under the Securities Act of 1933 or by means of an exemption from the registration requirements thereof.

Philips to acquire Brazilian patient monitoring and critical care company Dixtal Biomédica e Tecnologia

Tuesday, May 13, 2008

• Move further bolsters Philips’ healthcare presence in high-growth emerging markets

• Dixtal’s economy- to mid-range patient monitoring, anesthesia and ventilation products to broaden Philips’ presence in key ‘critical care’ market

Amsterdam, the Netherlands and São Paulo, Brazil – Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced it has reached an agreement to acquire Brazilian-based Dixtal Biomédica e Tecnologia (“Dixtal”). Dixtal is a leading Brazilian manufacturer of in-hospital patient monitoring, anesthesia, ventilation equipment, and ECG (electrocardiogram) as well as other sensors for vital sign measurements. Dixtal will become part of the Patient Monitoring business within Philips’ Healthcare sector, and Philips expects Dixtal’s financial results will be consolidated in this business as of the third quarter of 2008. The terms of the deal were not disclosed.

Today’s announcement marks another step Philips is taking to expand its presence in high-growth healthcare markets in emerging economies, following the company’s earlier announced acquisitions of healthcare companies Shenzhen Goldway Industrial in China and VMI Sistemas Medicos in Brazil. In commenting on the deal, Mr. Daurio Speranzini Júnior, Senior Vice-President of Philips Healthcare Latin America, said: “Emerging markets represent a real opportunity for us to keep growing our healthcare business at Philips. If you just take Latin America, our addressable healthcare market in 2007 was estimated to be valued at approximately EUR 1.2 billion, and growing at twice the rate of developed markets. Acquiring Dixtal will help us further tap into that growth.”

Today’s agreement with Dixtal will also bolster Philips’ presence in the global medical equipment market for ‘critical care’ – that is, the medical equipment used to care for patients experiencing acute and critical illness or injury. Mr. Speranzini Júnior explains: “In the hospital, a key component of critical care is patient monitoring, and Philips already enjoys a leading global position in this market. Acquiring Dixtal will not only extend Philips’ product portfolio to include Dixtal’s mid- to economy-range patient monitoring products, but through this move we’ll gain access to other key components of critical care – Dixtal’s anesthesia machines and its invasive ventilation products. So this acquisition complements Philips’ recent move into the non-invasive ventilation business through our acquisition earlier this year of US-based Respironics. And since Dixtal and Philips use the same distribution channels vis-à-vis hospitals for all of our critical care businesses, we can expect significant synergies coming out of this collaboration.”

Founded in 1978, Dixtal is a privately-held healthcare company headquartered in São Paulo, Brazil. Dixtal employs approximately 300 people, mainly in Brazil, of which 60 work in research & development. “At Dixtal, we’re committed to innovation, aesthetics, and product evolution, and our passion to serve people has helped us become a leading medical equipment company in Brazil. Since being founded 30 years ago, we’ve focused on helping hospitals provide the optimum in critical care. We believe that combining our culture and capabilities with those of a world class company like Philips will help us serve society better and expand our presence in Latin America and beyond,” said Albert Holzhacker, President of Dixtal.

Over the last four years, Dixtal has tripled its revenues. Following completion of the acquisition, growth is expected to accelerate further as Philips leverages Dixtal’s strong contacts to local hospitals and distributors, while Dixtal capitalizes on Philips’ global presence for its products. Philips has an extensive presence in critical care through its leading position in the global patient monitoring market, which in 2007 was estimated to be approximately USD 3 billion or approximately EUR 2 billion.

For further information, please contact:

Jayson Otke
Philips Corporate Communications
Tel: +31 20 5977215
Email: jayson.otke@philips.com

Andre Manning
Philips Healthcare
Tel: +1 646 508 454
Email: andre.manning@philips.com

Fábio Lopes
Philips Brazil Corporate Comunications
Tel: +55 11 2125 0463
Email: fabio.lopes@philips.com

About Dixtal Biomédica e Tecnologia
Dixtal Biomédica e Tecnologia is a leading Brazilian patient monitoring and critical care equipment manufacturer, with headquarters in São Paulo. Founded in 1978 to develop and implement effective solutions for the healthcare segment, the company today employs approximately 300 people, 60 of them dedicated to research and development. Its complete portfolio includes physiological multiparametric monitors, electrocardiographs, oximeters, capnographs, a clinical management system, among other products.

Philips agrees to sell MedQuist stake to CBay Systems

Thursday, May 22, 2008

Amsterdam, the Netherlands and London, the United Kingdom – Royal Philips Electronics (AEX: PHI, NYSE: PHG) (“Philips”) today announced it has reached an agreement to sell its approximate 69.5% ownership interest in MedQuist Inc. (Pink Sheets: MEDQ.PK) to CBay Systems Holdings (AIM: CBAY) (“CBay”) for USD 11.00 per share, or approximately USD 285 million (approximately EUR 185 million). The USD 11.00 per share purchase price represents a premium of 47% over the most recent trading price of MedQuist’s stock. The acquisition of the approximate 69.5% shareholding in MedQuist will complement CBay Systems Holdings’ existing portfolio of businesses in medical transcription, healthcare technology, and healthcare financial services, including CBay Systems & Services Inc, CBay Systems Private Ltd. and Mirrus Systems.

The sale of Philips’ stake in MedQuist is expected to close during the third quarter of 2008, and is conditional upon applicable regulatory approvals, approval by CBay shareholders at a general meeting of shareholders, and the fulfillment of specific closing conditions. In connection with this transaction, Philips will receive cash and a promissory note equivalent to approximately USD 7.50 per share, amounting to approximately USD 195 million (approximately EUR 125 million). The remaining per share consideration of approximately USD 3.50 per share will be paid to Philips in the form of a 7-year bond convertible into common stock of CBay. The financial results related to this transaction, which are expected to be immaterial, will be booked under “Discontinued Operations” in Philips’ third quarter 2008 results.

Today’s announcement follows a November 2, 2007 announcement, in which Philips indicated its intention to proceed with the sale of its approximate 69.5% ownership interest, as well as a July 6, 2007 announcement, in which Philips indicated it viewed its stake in MedQuist as a non-core holding.

For more information, please contact:

Jayson Otke
Philips Corporate Communications
Tel: +31 20 5977215
Email: jayson.otke@philips.com

David Wolf
Philips Corporate Communications North America
Tel: +1 917 455 7857
Email: david.l.wolf@philips.com

Mark Court
For CBay Systems Holdings Ltd.
Buchanan Communications
Tel: + 44 (0) 20 7466 500
Email: markc@buchanan.uk.com

About CBay Systems Holdings Ltd.
CBay Systems Holdings Ltd. is the holding company for a portfolio of businesses, including CBay Systems & Services Inc, CBay Systems Private Ltd, and Mirrus Systems, that provide medical transcription, healthcare technology, and healthcare financial services to the US healthcare industry. CBay Systems Holdings Ltd trades under the CBAY symbol on the AIM market of the London Stock Exchange.

Forward looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements in this announcement are based upon information known to Philips on the date of this announcement. Philips undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Philips completes cancellation of 36.6 million shares

Tuesday, June 03, 2008

Amsterdam, The Netherlands – Royal Philips Electronics (NYSE:PHG, AEX:PHI) announced today that it has completed the cancellation of in total 36,653,831 shares which have been acquired for cancellation purposes during the period starting March 14, 2008 up to and including May 28, 2008 against an average repurchase price of EUR 24.34 per share. These shares have been repurchased under the EUR 5 billion share repurchase program Philips announced on December 19, 2007 which is currently being executed.

In connection with this share capital reduction, Philips has notified the Netherlands Authority for the Financial Markets (AFM) that it no longer holds 5 per cent of its own shares. As a result of this cancellation, Philips’ issued share capital as per today amounts to 1,046,265,843 shares.

For further information, please contact:

Arent Jan Hesselink
Philips Corporate Communications
Tel: +31 20 59 77415
Email: arentjan.hesselink@philips.com

Koninklijke Philips Electronics N.V. ———————————————————————————————————
(Translation of registrant’s name into English)

The Netherlands ———————————————————————————————————
(Jurisdiction of incorporation or organization)

Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands
——————————————————————————————————— (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: [x] Form 20-F [ ] Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: [ ] Yes [x] No